2000-11-23
Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)
Publication
Publication
British Journal of Haematology , Volume 111 - Issue 1 p. 277- 279
Additional Metadata | |
---|---|
, | |
doi.org/10.1046/j.1365-2141.2000.02402.x, hdl.handle.net/1765/62302 | |
British Journal of Haematology | |
Organisation | Department of Hematology |
de Vetten, M.P, Jansen, J.H, van der Reijden, B.A, Berger, M.S, Zijlmans, J.M, & Löwenberg, B. (2000). Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676). British Journal of Haematology, 111(1), 277–279. doi:10.1046/j.1365-2141.2000.02402.x
|